OZEM 📈 Roundhill GLP-1 & Weight - Overview
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • • Health
OZEM: GLP-1, Weight Loss, Pharmaceuticals, Biotechnology, Healthcare
The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.
Additional Sources for OZEM ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
OZEM ETF Overview
| Market Cap in USD | 46m |
| Category | Health |
| TER | 0.59% |
| IPO / Inception | 2024-05-20 |
OZEM ETF Ratings
| Growth 5y | -26.8% |
| Fundamental | - |
| Dividend | - |
| Rel. Strength Industry | -126 |
| Analysts | - |
| Fair Price Momentum | 21.78 USD |
| Fair Price DCF | - |
OZEM Dividends
No Dividends PaidOZEM Growth Ratios
| Growth Correlation 3m | -77.7% |
| Growth Correlation 12m | 19.3% |
| Growth Correlation 5y | 19.3% |
| CAGR 5y | -3.63% |
| CAGR/Mean DD 5y | -0.94 |
| Sharpe Ratio 12m | -0.37 |
| Alpha | -34.74 |
| Beta | 1.24 |
| Volatility | 39.62% |
| Current Volume | 34.6k |
| Average Volume 20d | 22.5k |
What is the price of OZEM stocks?
As of December 22, 2024, the stock is trading at USD 24.45 with a total of 34,600 shares traded.
Over the past week, the price has changed by -6.57%, over one month by -4.38%, over three months by -14.12% and over the past year by -3.63%.
As of December 22, 2024, the stock is trading at USD 24.45 with a total of 34,600 shares traded.
Over the past week, the price has changed by -6.57%, over one month by -4.38%, over three months by -14.12% and over the past year by -3.63%.
Is Roundhill GLP-1 & Weight a good stock to buy?
Probably not. Based on ValueRay Analyses, Roundhill GLP-1 & Weight (NASDAQ:OZEM) is currently (December 2024) not a good stock to buy. It has a ValueRay Growth Rating of -26.80 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OZEM as of December 2024 is 21.78. This means that OZEM is currently overvalued and has a potential downside of -10.92%.
Probably not. Based on ValueRay Analyses, Roundhill GLP-1 & Weight (NASDAQ:OZEM) is currently (December 2024) not a good stock to buy. It has a ValueRay Growth Rating of -26.80 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of OZEM as of December 2024 is 21.78. This means that OZEM is currently overvalued and has a potential downside of -10.92%.
Is OZEM a buy, sell or hold?
Roundhill GLP-1 & Weight has no consensus analysts rating.
Roundhill GLP-1 & Weight has no consensus analysts rating.
What are the forecast for OZEM stock price target?
According to ValueRays Forecast Model, OZEM Roundhill GLP-1 & Weight will be worth about 24.4 in December 2025. The stock is currently trading at 24.45. This means that the stock has a potential downside of -0.2%.
According to ValueRays Forecast Model, OZEM Roundhill GLP-1 & Weight will be worth about 24.4 in December 2025. The stock is currently trading at 24.45. This means that the stock has a potential downside of -0.2%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 24.4 | -0.2% |